H. Denison

发表

ST-segment changes and catecholamine-related myocardial enzyme release during alcohol withdrawal.

S. Jern, H. Denison, R. Jagenburg, 1997, Alcohol and alcoholism.

Predictors of either rapid healing or refractory reflux oesophagitis during treatment with potent acid suppression

P. Kahrilas, T. Persson, C. Howden, 2014, Alimentary pharmacology & therapeutics.

A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis.

P. Malfertheiner, J. Dent, P. Kahrilas, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The prevalence of alcoholism and its relation to cause of hospitalization and long‐term mortality in male somatic inpatients

J. Westin, H. Denison, S. Wallerstedt, 1995, Journal of internal medicine.

Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial

S. Kasner, S. Johnston, C. Molina, 2018, Stroke.

Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)

Mikhail V. Arkhipov, D. Tanné, C. Anderson, 2017, Circulation.

Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (Socrates) Trial: Rationale and Design

S. Johnston, C. Molina, G. Albers, 2015, International journal of stroke : official journal of the International Stroke Society.

Disability after minor stroke and TIA

S. Kasner, S. Johnston, B. Cucchiara, 2019, Neurology.

A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)

Akshay S. Desai, D. DeMets, P. Ponikowski, 2019, European journal of heart failure.

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin

A. Demchuk, J. Jeng, S. Vannier, 2020, Stroke.

Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial

Yongjun Wang, Mikael Knutsson, Gregory W Albers, 2020, Clinical trials.

Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial

S. Kasner, S. Johnston, C. Molina, 2017, The Lancet Neurology.

Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial

S. Johnston, C. Molina, G. Albers, 2019, International journal of stroke : official journal of the International Stroke Society.

Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)

S. Johnston, C. Molina, G. Albers, 2017, Stroke.

Ef fi cacy and safety of lesogaberan in gastro-oesophageal re fl ux disease : a randomised controlled trial

N. Shaheen, D. Silberg, H. Denison, 2013 .

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack

S. Johnston, C. Molina, P. Amarenco, 2021, Stroke.

Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.

S. Johnston, C. Molina, P. Amarenco, 2020, The New England journal of medicine.

Analysis of carbohydrate-deficient transferrin (CDT) in vitreous humour as a forensic tool for detection of alcohol misuse.

H. Denison, S. Wallerstedt, A. Berkowicz, 2003, Forensic science international.

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack

Hao Li, S. Johnston, C. Molina, 2022, Neurology.

Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke

A. Demchuk, J. Jeng, S. Vannier, 2020, JAMA neurology.

Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease.

P. Kahrilas, C. Howden, H. Denison, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Ischemic heart disease and epilepsy: two major causes of out-hospital natural death in male alcoholics.

H. Denison, C. Wendestam, S. Wallerstedt, 1995, Forensic science international.

Influence of increased adrenergic activity and magnesium depletion on cardiac rhythm in alcohol withdrawal.

S. Jern, H. Denison, R. Jagenburg, 1994, British heart journal.

Paracetamol medication and alcohol abuse: a dangerous combination for the liver and the kidney.

H. Denison, S. Wallerstedt, J. Kaczynski, 1987, Scandinavian journal of gastroenterology.

Gender differences in symptoms in partial responders to proton pump inhibitors for gastro-oesophageal reflux disease

N. Vakil, A. Niklasson, A. Rydén, 2015, United European gastroenterology journal.

Reducing Adverse Effects During Drug Development: The Example of Lesogaberan and Paresthesia.

M. Ruth, J. Jensen, E. Söderlind, 2016, Clinical therapeutics.

Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study

J. Gisbert, P. Kahrilas, C. Howden, 2013, Alimentary pharmacology & therapeutics.

Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial

H. Tornqvist, A. Himmelmann, C. Nilsson, 2014, Diabetes, obesity & metabolism.

Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy

P. Kahrilas, C. Howden, H. Denison, 2013, Gut.

Concomitant Symptoms Itemized in the Reflux Disease Questionnaire Are Associated With Attenuated Heartburn Response to Acid Suppression

P. Kahrilas, C. Howden, H. Denison, 2012, The American Journal of Gastroenterology.

Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease.

G. Boeckxstaens, D. Silberg, D. Sifrim, 2010, Gastroenterology.

CLINICAL—ALIMENTARY TRACT Effects of Lesogaberan on Reflux and Lower Esophageal Sphincter Function in Patients With Gastroesophageal Reflux Disease

G. Boeckxstaens, D. Silberg, D. Sifrim, 2010 .

A Randomized, Comparative Trial of a Potassium-Competitive Acid Blocker (AZD0865) and Esomeprazole for the Treatment of Patients With Nonerosive Reflux Disease

J. Dent, P. Lundborg, P. Kahrilas, 2008, The American Journal of Gastroenterology.

A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial

G. Boeckxstaens, D. Silberg, H. Denison, 2011, Gut.

Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first‐time‐in‐human single‐dose study

C. Karlsson, C. Nilsson, H. Denison, 2013, Diabetes, obesity & metabolism.

Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial

N. Shaheen, D. Silberg, H. Denison, 2012, Gut.

Bacterial overgrowth after high-dose corticosteroid treatment.

H. Denison, S. Wallerstedt, 1989, Scandinavian journal of gastroenterology.

Translational gastrointestinal pharmacology in the 21st century: 'the lesogaberan story'.

G. Boeckxstaens, M. Ruth, J. Jensen, 2011, Current opinion in pharmacology.

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.

S. Johnston, C. Molina, G. Albers, 2016, The New England journal of medicine.

The significance of coronary death for the excess mortality in alcohol-dependent men.

A. Odén, H. Denison, C. Wendestam, 1997, Alcohol and alcoholism.

Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations

N. Vakil, A. Niklasson, A. Rydén, 2014, BMC Gastroenterology.

Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors

N. Vakil, A. Rydén, H. Denison, 2013, Scandinavian journal of gastroenterology.

Validation of the Reflux Symptom Questionnaire Electronic Diary in Partial Responders to Proton Pump Inhibitor Therapy

J. Paty, D. Silberg, N. Vakil, 2012, Clinical and Translational Gastroenterology.

Carbohydrate-deficient transferrin in vitreous humour: a marker of possible withdrawal-related death in alcoholics.

H. Denison, S. Wallerstedt, A. Berkowicz, 2001, Alcohol and alcoholism.

Esophageal Mucosal Breaks in Gastroesophageal Reflux Disease Partially Responsive to Proton Pump Inhibitor Therapy

N. Shaheen, D. Silberg, H. Denison, 2013, The American Journal of Gastroenterology.

The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design

S. Johnston, C. Molina, P. Amarenco, 2019, International journal of stroke : official journal of the International Stroke Society.

M1875 Efficacy and Tolerability of the Novel Reflux Inhibitor, AZD3355, As Add-On Treatment in GERD Patients with Symptoms Despite Proton Pump Inhibitor Therapy

G. Boeckxstaens, D. Silberg, H. Denison, 2009 .

M1861 Effect of AZD3355, a Novel GABAB Agonist, On Reflux and Lower Esophageal Sphincter Function in Patients with GERD with Symptoms Despite Proton Pump Inhibitor Treatment

G. Boeckxstaens, D. Silberg, D. Sifrim, 2009 .

Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial

S. Johnston, C. Molina, G. Albers, 2019, Stroke.

Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA

S. Johnston, C. Molina, P. Amarenco, 2020, New England Journal of Medicine.

Diagnosis of pyogenic liver abscess via liver scanning with indium-111 labelled granulocytes.

H. Denison, S. Wallerstedt, 1989, Scandinavian Journal of Infectious Diseases.

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.

S. Johnston, G. Albers, P. Amarenco, 2016, The New England journal of medicine.

Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial

S. Johnston, P. Amarenco, Yongjun Wang, 2023, BMJ Neurology Open.

Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke

Hao Li, S. Johnston, C. Molina, 2021, JAMA neurology.

Mikhail V. Arkhipov, D. Tanné, C. Anderson, 2017, Circulation.

Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (Socrates) Trial: Rationale and Design

S. Johnston, G. Albers, P. Amarenco, 2015, International journal of stroke : official journal of the International Stroke Society.

Editorial: healing of refractory reflux oesophagitis – an ongoing unmet clinical need; authors' reply

P. Kahrilas, T. Persson, H. Denison, 2014, Alimentary pharmacology & therapeutics.

Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source

S. Kasner, P. Amarenco, Yongjun Wang, 2017, Stroke.